A carregar...
ACTR-26. TOXICITY AND EFFICACY OF LOMUSTINE PLUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS
BACKGROUND: Bevacizumab combined with chemotherapy has shown high response rates in recurrent glioblastoma patients and responding patients have improved survival and quality of life. The Danish treatment recommendations for recurrent glioblastoma patients were recently changed by replacing irinotec...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692348/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.021 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|